Fortress Biotech, Inc. financial data

Symbol
FBIO, FBIOP on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
CORONADO BIOSCIENCES INC (to 4/27/2015)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 133 % -2.44%
Quick Ratio 13.3 % +26.6%
Debt-to-equity 750 % +1.4%
Return On Equity 654 %
Return On Assets -32.1 % +8.94%
Operating Margin -170 % +22.5%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 27.6M shares +209%
Entity Public Float 52.9M USD -20.3%
Common Stock, Value, Issued 28K USD +211%
Weighted Average Number of Shares Outstanding, Basic 19.7M shares +163%
Weighted Average Number of Shares Outstanding, Diluted 19.7M shares +163%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 62.5M USD -22.8%
Research and Development Expense 61M USD -52%
Costs and Expenses 169M USD -34.8%
Operating Income (Loss) -106M USD +40.2%
Nonoperating Income (Expense) -17M USD -265%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.6M USD -152%
Income Tax Expense (Benefit) 449K USD -23.9%
Net Income (Loss) Attributable to Parent -48.5M USD +38%
Earnings Per Share, Basic -2.93 USD/shares +84.9%
Earnings Per Share, Diluted -0.76 USD/shares +19.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.9M USD -18.6%
Accounts Receivable, after Allowance for Credit Loss, Current 10.7M USD +33.6%
Inventory, Net 11.8M USD +6.93%
Assets, Current 86.3M USD -11.8%
Property, Plant and Equipment, Net 3.4M USD -50.4%
Operating Lease, Right-of-Use Asset 14.2M USD -19.2%
Other Assets, Noncurrent 3.35M USD -30.6%
Assets 127M USD -15.6%
Accounts Payable, Current 34M USD -23.9%
Accrued Liabilities, Current 64.5M USD -20.8%
Liabilities, Current 70.3M USD -27.8%
Deferred Income Tax Liabilities, Net 233K USD
Operating Lease, Liability, Noncurrent 15.3M USD -19.3%
Other Liabilities, Noncurrent 1.75M USD +2.76%
Liabilities 140M USD -14.6%
Retained Earnings (Accumulated Deficit) -734M USD -7.08%
Stockholders' Equity Attributable to Parent 21.2M USD +26.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -12.7M USD +3.81%
Liabilities and Equity 127M USD -15.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD +41.3%
Net Cash Provided by (Used in) Financing Activities 27.9M USD +25.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 27.6M shares +209%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.47M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 60.9M USD -18.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD -42.5%
Deferred Tax Assets, Valuation Allowance 366M USD +15.2%
Deferred Tax Assets, Gross 374M USD +14.7%
Operating Lease, Liability 17.8M USD -16.6%
Depreciation 1.06M USD -62.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 21.8M USD -19.1%
Property, Plant and Equipment, Gross 15.4M USD 0%
Operating Lease, Liability, Current 2.51M USD +4.19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.27M USD -13.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.54M USD -6.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.95M USD -28.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.92M USD -17.3%
Deferred Tax Assets, Operating Loss Carryforwards 211M USD +6.6%
Preferred Stock, Shares Issued 3.43M shares 0%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 3.2M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.97M USD -7.05%
Operating Lease, Payments 920K USD +5.02%
Additional Paid in Capital 755M USD +7.54%
Preferred Stock, Shares Outstanding 3.43M shares 0%
Amortization of Intangible Assets 814K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 7.52M USD -4.8%
Share-based Payment Arrangement, Expense 20.1M USD +6.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%